A peptidase inhibitor cocktail enhanced pain relief from met-enkephalin, beta-endorphin, and electroacupuncture, but not from dynorphin — revealing peptide-specific enzyme vulnerabilities.
Acupuncture enhanced tooThe enzyme inhibitors boosted electroacupuncture analgesia, proving acupuncture works partly through endogenous opioid peptides
What the researchers found
Peptidase inhibitor mixture enhanced antinociception from met-enkephalin, beta-endorphin, and electroacupuncture, but not dynorphin-(1-13).
Why it matters
The body makes its own painkillers (opioid peptides) but enzymes break them down quickly. This study shows that blocking those enzymes can dramatically improve natural pain relief, pointing toward a drug strategy that works with the body rather than replacing its signals.
How the study worked
Rats received intrathecal injections of the peptidase inhibitor mixture (amastatin, captopril, phosphoramidon) followed by opioid peptides or electroacupuncture at the Hoku point. Pain threshold was measured by hind paw pressure test.
What this study cannot tell us
Animal study in rats using spinal injection. The enzyme inhibitors were given directly into the spinal canal, not by mouth. The combination approach has not been tested in humans.
How to read the evidence
Moderate — animal study with multiple comparisons and a revealing dissociation between peptide types.
When this study was published
Published in 1994 (32 years ago). Dual enkephalinase inhibitors have since been developed and tested in humans.
The bigger picture
Instead of giving people opioid drugs, we could boost their own natural painkillers by blocking the enzymes that destroy them. This is potentially a non-addictive approach to pain management.
Questions still open
- Could peptidase inhibitors be developed as non-addictive pain medications?
- Why is dynorphin resistant to this enzyme inhibitor combination?
Common questions
How does blocking enzymes help with pain?
Is this related to how acupuncture works?
Read the original research
Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats.
Japanese journal of pharmacology, 66(3), 337-45
Citation
Kishioka, S; Miyamoto, Y; Fukunaga, Y; Nishida, S; Yamamoto, H. (1994). Effects of a mixture of peptidase inhibitors (amastatin, captopril and phosphoramidon) on Met-enkephalin-, beta-endorphin-, dynorphin-(1-13)- and electroacupuncture-induced antinociception in rats.. Japanese journal of pharmacology, 66(3), 337-45.